BANK OF AMERICA CORP /DE/ - IMMUNOVANT INC ownership

IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$23,141,185
+589.7%
602,792
+240.8%
0.00%
Q2 2023$3,355,035
-47.2%
176,860
-56.8%
0.00%
-100.0%
Q1 2023$6,356,216
+52.5%
409,814
+74.5%
0.00%
Q4 2022$4,167,754
+2835.0%
234,803
+821.8%
0.00%
Q3 2022$142,000
+153.6%
25,472
+76.6%
0.00%
Q2 2022$56,000
-61.1%
14,424
-44.9%
0.00%
Q1 2022$144,000
-92.5%
26,167
-88.4%
0.00%
Q4 2021$1,921,000
+132.0%
225,448
+136.6%
0.00%
Q3 2021$828,000
-41.9%
95,306
-29.3%
0.00%
Q2 2021$1,425,000
-28.5%
134,721
+8.4%
0.00%
Q1 2021$1,993,000
+60.7%
124,293
+362.6%
0.00%
Q4 2020$1,240,000
+5.3%
26,868
-19.7%
0.00%
Q3 2020$1,178,000
+303.4%
33,450
+178.8%
0.00%
Q2 2020$292,000
+122.9%
11,997
+42.6%
0.00%
Q1 2020$131,0008,4120.00%
Other shareholders
IMMUNOVANT INC shareholders Q2 2022
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders